To earn trust, every day.
About the company News & MediaResponsibility
Our combination with Organon BioSciences is a transformational step on Schering-Plough’s continuing journey as we build a high-performance company for the long term.
November 3, 2009Merck and Schering-Plough to Complete Merger Today
November 2, 2009Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
November 2, 2009Schering-Plough Announces Sponsorship of Rabies-Control Projects in India
November 2, 2009Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies
November 1, 2009Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting
October 30, 2009U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma
October 29, 2009Merck and Schering-Plough Receive Approvals From U.S. Federal Trade Commission, Swiss Competition Commission and Canadian Competition Bureau for Merger
October 23, 2009Merck and Schering-Plough Receive Approval From European Commission for Merger
October 22, 2009Schering-Plough Reports Financial Results for 2009 Third Quarter
